John Eu-Li Wong

Prof John Eu-Li Wong became a member, in 2019, of the US National Academy of Medicine, considered among the highest honours in the fields of health and medicine. As Senior Vice-President of health innovation and translation at the National University of Singapore (NUS), he is actively involved in developing biomedical sciences as a key pillar of Singapore’s economy, as well as Singapore’s first academic health system between the National University Hospital and NUS.

Prof Wong, who studied at NUS and did his residency and fellowship at the New York Hospital-Cornell Medical Center, is a medical oncologist-haematologist specialising in diagnosing and treating cancers and blood diseases.

Wong is also a member of the World Economic Forum Global Agenda Council on Personalised and Precision Medicine; the Nature Index Panel of Senior Medical Advisers; the international editorial board of The American Journal of Medicine; and the editorial board of the Journal of the American Medical Association. He jointly founded the Cancer Therapeutics Research Group, a multi-national consortium of nine academic institutions, and has served as a member of the International Education Council for Molecular Targeted Therapy for Cancer, the American Society of Clinical Oncology International Affairs Committee, and the International Oncology Foundation advisory board.